SCHEMBL4024937

SCHEMBL4024937

CC(C)(C)OC(=O)N1CCC(Cc2ccccc2)(c2ncc(-c3ccncc3)n2-c2ccc(F)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 2/20 0.44
OPRK1 P41145 1/20 0.44
TP53 P04637 2/20 0.42
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
CYP46A1 Q9Y6A2 1/20 0.41
TACR1 P25103 1/20 0.40
GPR119 Q8TDV5 2/20 0.39
LMNA P02545 1/20 0.38
NAMPT P43490 1/20 0.38
ACHE P22303 1/20 0.38
RORC P51449 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
CCNT1 O60563 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CDK9 P50750 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4024940 0.76 MAPK14 (0.45) CYP46A1
SCHEMBL25133820 0.68 GPR119 (0.52) OPRD1OPRK1PDE4APDE4BPDE4C
SCHEMBL8115847 0.68 TACR1 (0.52) OPRD1OPRK1TACR1GPR119ACHE
SCHEMBL5672784 0.68 MEN1 (0.47) OPRD1OPRK1TP53TACR1GPR119
SCHEMBL2185224 0.67 KDM1A (0.46) OPRD1OPRK1TACR1RORCHDAC1
SCHEMBL4025346 0.67 MAPK14 (0.44)
SCHEMBL2465494 0.67 TP53 (0.52) TP53TACR1LMNANAMPTACHE
SCHEMBL18921641 0.67 GPR119 (0.53) OPRD1OPRK1PDE4APDE4BPDE4C
SCHEMBL14357682 0.67 KDM1A (0.48) OPRD1OPRK1TACR1RORCHDAC1
SCHEMBL25133817 0.67 GPR119 (0.53) OPRD1OPRK1PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0854870-B1 SUBSTITUTED IMIDAZOLES HAVING ANTI-CANCER AND CYTOKINE INHIBITORY ACTIVITY MERCK & CO INC (US) 2009-06-10 EP disclosed
CN-1117082-C Substituted imidazoles having anti-cancer and cytokine inhibitory activity MERCK & CO INC (US) 2003-08-06 CN disclosed
US-6083949-A FOR TREATING CANCER IN WHICH RAF KINASE IS IMPLICATED, AS WELL AS COMPOUNDS WHICH INHIBIT, SUPPRESS OR ANTAGONIZE THE PRODUCTION OR ACTIVITY OF CYTOKINES SUCH AS INTERLEUKINS AND TUMOR NECROSIS FACTOR MERCK & CO., INC. (US) 2000-07-04 US disclosed
CN-1203590-A Substituted imidazoles having anti-cancer and cytokine inhibitory activity MERCK & CO INC (US) 1998-12-30 CN disclosed